in this issue:
Severe portal hypertension: risk factor for hepatic decompensation
Effective HAART reduces HBV risk in HIV-infected men
Risk factors for fibrosis progression in HCV
Sofosbuvir+velpatasvir promising in HCV GT2/3
Managing HBV in pregnancy: position paper
TLR responses: potential biomarkers of HBeAg seroconversion?
Ombitasvir, paritaprevir + ritonavir in HCV GT1b
Knowledge and prevalence of HCV: a Dunedin study
Antenatal screening for HIV infection cost-effective
Increase in preventable liver transplants in Australia and NZ
Please login below to download this issue (PDF)